Angiogenesis Inhibitors
One promising avenue of cancer research is the study of a group of compounds called angiogenesis inhibitors. These are drugs that block the development of new blood vessels, a process known as angiogenesis.
By blocking the development of new blood vessels, researchers hope to cut off the tumor's supply of oxygen and nutrients. This in turn might stop the tumor from growing and spreading to other parts of the body.
Next Section > |